UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 2, 2020 9:00 A.M.
Form:
S-4
CIK:
0001228627
Company Name:
REXAHN PHARMACEUTICALS, INC.
File Number:
333-239702